Transplant MedicineConfirmed
CAR-T Helped Two Highly Sensitized Kidney Patients Receive Transplants
Penn researchers used dual CAR-T therapy to reduce harmful antibodies in two highly sensitized kidney candidates, enabling both to receive kidney transplants.
Why now
A cancer-born cell therapy may have opened a transplant path for patients who were almost impossible to match.
- Overclaim risk
- high
- Primary source
- Official
- Published
- Jun 25, 2026
Read brief ->